Your browser doesn't support javascript.
loading
Early switch to second-line tyrosine kinase inhibitor in chronic myeloid leukemia patients failing to achieve early molecular response.
Klil-Drori, Adi J; Yin, Hui; Azoulay, Laurent; Harnois, Michaël; Gratton, Michel-Olivier; Del Corpo, Alexa; Olney, Harold J; Delage, Robert; Laneuville, Pierre; Mollica, Luigina; Busque, Lambert; Assouline, Sarit E.
Affiliation
  • Klil-Drori AJ; Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada.
  • Yin H; Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada.
  • Azoulay L; Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada.
  • Harnois M; Department of hematology, Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada.
  • Gratton MO; Department of hematology, Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada.
  • Del Corpo A; Segal Cancer Center, Jewish General Hospital, Montreal, Quebec, Canada.
  • Olney HJ; Department of hematology, CHUM, Montreal, Quebec, Canada.
  • Delage R; Centre Universitaire d'Hématologie et d'Oncologie de Québec, CHU de Québec, Québec, QC, Canada.
  • Laneuville P; McGill University Health Centre Research Institute, Montreal, Quebec, Canada.
  • Mollica L; Department of hematology, Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada.
  • Busque L; Department of hematology, Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada.
  • Assouline SE; Segal Cancer Center, Jewish General Hospital, Montreal, Quebec, Canada.
Am J Hematol ; 92(10): E602-E604, 2017 10.
Article in En | MEDLINE | ID: mdl-28670773
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Registries / Fusion Proteins, bcr-abl / Gene Dosage / Protein Kinase Inhibitors / Imatinib Mesylate Type of study: Evaluation_studies / Observational_studies / Prognostic_studies Limits: Female / Humans / Male Language: En Journal: Am J Hematol Year: 2017 Type: Article Affiliation country: Canada
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Registries / Fusion Proteins, bcr-abl / Gene Dosage / Protein Kinase Inhibitors / Imatinib Mesylate Type of study: Evaluation_studies / Observational_studies / Prognostic_studies Limits: Female / Humans / Male Language: En Journal: Am J Hematol Year: 2017 Type: Article Affiliation country: Canada